NeuroScientific Biopharmaceuticals Limited (NEUROSCIEN FPO [NSB]) aksje
NSB.AX
Stengt$0.0900-0.0020 (-2.17%)
Laster graf...
NEUROSCIEN FPO [NSB]
Market Cap
$29,931,816
Åpning0.0970
Høy0.0970
Lav0.0900
Volum202.56k
P/EN/A
Markedsverdi29.93M
52-ukers høy0.2600
52-ukers lav0.0510
Gj.sn. volum357.5k
UtbytteN/A
Beta1.12
EPS-0.0200
Om NeuroScientific Biopharmaceuticals Limited (NEUROSCIEN FPO [NSB]) aksje
NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Perth, Australia.
Selskapsinformasjon
Børs: ASX (ASX)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
216 St Georges Terrace
6000 Perth, Australia
6000 Perth, Australia
Telefon: + 61 8 6268 2641
Nettside: https://neuroscientific.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
0.43
↑ 377.8%
Gjennomsnittlig kursmål
0.43
↑ 377.8%
Median kursmål
0.43
↑ 377.8%
Høyeste kursmål
0.43
↑ 377.8%